FDA approves prefilled syringe for AVONEX.

Publication: PR Newswire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2003 PR Newswire Association LLC

Cambridge, Massachusetts -- Cambridge, Massachusetts, May 29 /PRNewswire/ -- - Only once-a-week Multiple Sclerosis therapy now even more convenient

Biogen, Inc. today announced the U.S. Food and Drug Administration(FDA) has approved a new prefilled syringe for AVONEX(R) (Interferon beta-1a), designed to make treatment even more convenient for people with multiple sclerosis (MS).

(LOGO: http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO )

AVONEX, the only once-a-week treatment for MS, is now approved in a convenient, prefilled syringe that makes it even easier to administer. Biogen expects the prefilled syringe to be available in August and replace the currently available form of AVONEX. As with the current form of AVONEX, the new formulation will be...

Read the full article for free courtesy of your local library.